Biofrontera (BFRI) Return on Equity (2021 - 2025)

Biofrontera's Return on Equity history runs 5 years deep, the most recent figure standing at 0.03% for Q4 2025.

• In Q4 2025, Return on Equity rose 1.0% year-over-year to 0.03%; the TTM figure through Dec 2025 stood at 0.03% (up 1.0% YoY), while the FY2025 annual figure was 0.01%, up 2.0% from the prior year.
• Return on Equity was 0.03% for Q4 2025 at Biofrontera, down from 0.05% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.74% in Q1 2024 to a low of 0.22% in Q2 2021.
• Historically, Return on Equity has averaged 0.02% across 5 years, with a median of 0.02% in 2024.
• The sharpest annual moves came in 2024 and 2025: Return on Equity jumped 75 bps in 2024, then slumped 79 bps in 2025.
• A 5-year view of Return on Equity shows it stood at 0.12% in 2021, then sank by 100 bps to 0.0% in 2022, then tumbled by 24969 bps to 0.07% in 2023, then surged by 48 bps to 0.04% in 2024, then grew by 25 bps to 0.03% in 2025.
• The last three Return on Equity figures came in at 0.03% (Q4 2025), 0.05% (Q3 2025), and 0.08% (Q2 2025), per Business Quant data.